Magnesium Malate for Health & Longevity

Created on 11/07/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Opus 5.5 – Audit

Magnesium malate is a dietary supplement pairing magnesium with malic acid, a natural fruit acid, used to supply magnesium. Its best-supported benefits, a small drop in blood pressure, better blood sugar control in people with or at risk of diabetes, fewer migraines and possibly faster sleep onset, come almost entirely from other magnesium forms; malate-specific evidence is thin. Main risks: loose stools and, with reduced kidney function, magnesium accumulation. (Full Review)

Protocol

Dose basis
Elemental magnesium
Malate trihydrate is about 11% magnesium: 3,750 mg supplies 425 mg
General supplementation
150–200 mg/day starting amount
Rhonda Patrick, favoring organic salts such as malate; the dimagnesium malate study used 500 mg/day
Blood pressure and metabolic goals
Median 368 mg/day for about 3 months
Trials of other salts; slightly above the 350 mg supplemental upper level
Time to effect
Blood pressure
From about 1 month
Trials of other magnesium salts
Red blood cell magnesium
+6% by 30 days, +30% by 90 days
Dimagnesium malate with B vitamins; body stores change over weeks
Fibromyalgia
Studies ran 2 months or longer
Improvement only in studies without a control group

Benefits

Contraindications
  • Reduced kidney function (eGFR ≤55 mL/min, dialysis)
  • Myasthenia gravis
  • Heart block or marked slow heart rate
  • Bowel obstruction or severe active diarrhea
Key Interactions
  • Fluoroquinolone antibiotics (ciprofloxacin)
  • Tetracycline antibiotics (doxycycline)
  • Bisphosphonates (alendronate)
  • Integrase inhibitors (dolutegravir)
  • Levothyroxine
  • Gabapentinoids (gabapentin)
  • Statins (rosuvastatin)
  • Proton pump inhibitors (omeprazole)
  • Other magnesium-containing products (magnesium oxide laxatives, magnesium hydroxide antacids)
  • High-dose zinc supplements (142 mg/day zinc)
  • Loop and thiazide diuretics (furosemide, hydrochlorothiazide)
  • Alcohol
  • Antihypertensive drugs (amlodipine)
  • Aminoglycoside antibiotics (gentamicin)
Theoretical (inferred from mechanism)
  • Blood-pressure-lowering supplements (potassium, beetroot nitrate)
  • Potassium-sparing diuretics (spironolactone)

Risk & Side Effects

  • High:
  • Medium:
  • Low: Gastrointestinal adverse events, hypermagnesemia with reduced kidney function or high intake, worsened muscle weakness in myasthenia gravis, possible newborn death signal in pregnancy
  • Speculative: Blunted blood vessel relaxation

Monitoring

Marker Target Why
Serum magnesium ≥0.85 mmol/L (≈2.07 mg/dL), proposed lower limit; stop or reduce at ≥2.5 mg/dL Confirms intake and flags accumulation
Red blood cell magnesium 4.2–6.8 mg/dL Reflects tissue stores over weeks
eGFR and creatinine Creatinine 0.6–1.3 mg/dL; eGFR: no established target, track change from own baseline Safety check: low values stop or limit use
Blood pressure No established target; track change from own baseline Expected to change: modest lowering reported

Cadence: Baseline before starting; 8–12 weeks after starting or changing the dose, then every 6–12 months; every 3 months with reduced kidney function or on proton pump inhibitors or diuretics.

Qualitative Assessment

  • Bowel habits (loose stools signal the dose ceiling)
  • Sleep onset and sleep quality
  • Muscle cramps, twitching and soreness
  • Energy and fatigue levels
  • Headache or migraine frequency
  • Mood